Joseph Shulman

Technik-/Wissenschafts-/F&E-Leiter bei RHYTHM PHARMACEUTICALS, INC.

Vermögen: 1 145 $ am 30.04.2024

49 Jahre

Health Technology

Consumer Services

Aktive Positionen von Joseph Shulman

Unternehmen	Position	Beginn	Ende
RHYTHM PHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	27.07.2020	-

Unternehmen	Position	Beginn	Ende
RA PHARMACEUTICALS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.07.2019	01.07.2020
NOVELION THERAPEUTICS INC.	Technik-/Wissenschafts-/F&E-Leiter	01.09.2014	01.07.2019

Boston University	Masters Business Admin
University of Miami	Undergraduate Degree

International

Vereinigte Staaten	5
Kanada	2

Operativ

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
RHYTHM PHARMACEUTICALS, INC.	Health Technology

Private Unternehmen	2
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology
Novelion Therapeutics, Inc. Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada.	Health Technology

Private Unternehmen

Health Technology